Beta-hydroxybutyrate for active Crohn's disease when starting new therapy
Part of Digestive system clinical trials.
This study tests whether a natural substance called beta-hydroxybutyrate (BHB) can help treat active Crohn's disease when you start a new prescription therapy. It aims to see if adding BHB is safe and practical.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have been diagnosed with Crohn's disease
- Your Crohn's is active (based on a stool test or a scope in the last 3 months)
- You are about to start a new biologic or small molecule treatment
- You have not used beta-hydroxybutyrate supplements, a ketogenic diet, or intermittent fasting in the last 4 weeks
- You have not taken antibiotics in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a behavioral therapy program can help people with active Crohn's disease feel better when they start a new biologic medication. You'll get extra support to manage stress and symptoms while you and your doctor adjust your treatment.
This study tests whether combining a specific diet with biologic medicines can reduce active inflammation and symptoms of Crohn’s disease. It may help people who still have active disease in the bowel despite prior care.
This trial tests an experimental drug for people with moderate to severe Crohn's disease who haven't responded well to other treatments. The drug aims to reduce inflammation and may help improve symptoms.
This trial tests whether adding a special liquid diet (partial enteral nutrition) to a new advanced Crohn's medication can help control disease better than the medication alone.
This study tests whether starting adalimumab along with partial enteral (tube or drink) nutrition helps control active Crohn’s disease. It may help reduce symptoms and inflammation compared with standard care alone.
This trial tests whether taking a supplement called beta-hydroxybutyrate (BHB) can help prevent polyps in people with familial adenomatous polyposis (FAP), a condition that causes many polyps in the colon. The study has two parts: one for people who have already had colon surgery, and another for those who still have their colon.
Hear when a new Crohn’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.